Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
30 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-presents-latest-research-and-clinical-advancement-across-leading-epilepsy-portfolio-at-international-epilepsy-congress-302541780.html
06 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucbs-hs-summit-united-patients-and-experts-to-drive-progress-in-hidradenitis-suppurativa-awareness-and-treatment-302521334.html
09 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-extends-its-bimzelx-get-yourself-back-direct-to-consumer-campaign-for-the-hidradenitis-suppurativa-community-302499427.html
08 Jul 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/ucb-extends-bimzelx-ad-campaign-wake-hidradenitis-suppurativa-approval
28 Jun 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/ucbs-fintepla-shows-potential-expand-3rd-epilepsy-indication
27 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ucb-announces-positive-results-from-gemz-phase-3-study-of-fenfluramine-in-cdkl5-deficiency-disorder-302492480.html
REF. STANDARDS & IMPURITIES
Inspections and registrations
ABOUT THIS PAGE
UCB Pharma S.A is a supplier offers 14 products (APIs, Excipients or Intermediates).
Find a price of Cetirizine Dihydrochloride bulk with DMF offered by UCB Pharma S.A
Find a price of Buclizine Hydrochloride bulk offered by UCB Pharma S.A
Find a price of Calcitonin bulk offered by UCB Pharma S.A
Find a price of Carbetapentane bulk offered by UCB Pharma S.A
Find a price of Hydroxyzine Hydrochloride bulk offered by UCB Pharma S.A
Find a price of Hydroxyzine Pamoate bulk offered by UCB Pharma S.A
Find a price of Meclizine Hydrochloride bulk offered by UCB Pharma S.A
Find a price of Mesna bulk offered by UCB Pharma S.A
Find a price of Methylphenidate Hydrochloride bulk offered by UCB Pharma S.A
Find a price of Pentoxiverine citrate bulk offered by UCB Pharma S.A
Find a price of Piracetam bulk offered by UCB Pharma S.A
Find a price of FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES bulk offered by UCB Pharma S.A
Find a price of FACILITIES AND GENERAL OPERATING PROCEDURES bulk offered by UCB Pharma S.A
Find a price of Brivaracetam bulk offered by UCB Pharma S.A